Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 5473 - 5480 of 12142 results
Time-Barred IPR Petitioners Have Separate Standing to Appeal PTAB Decisions
February 12, 2019| Blog| Viewpoint
End Of Spouse Work Authorization Could Drive Away H-1Bs
February 12, 2019| News
Women Increase Share of US Patents, But Only to 12 Percent
February 12, 2019| News
45 States Now Have Biosimilar Substitution Laws
February 11, 2019| Blog| Viewpoint
How to Enforce an Arbitration Subpoena: Jurisdiction and Venue Basics
February 11, 2019| Blog| Viewpoint
ML Strategies Health Care Preview - Week of February 11, 2019
February 11, 2019| Blog| Viewpoint
Separate Federal and State Background Check Disclosure Forms Are Required in California, Says 9th Circuit Court of Appeals
February 11, 2019| Blog| Viewpoint
CPSC Commissioner Elliot Kaye Issues Statement Providing a Framework of Safety for the Internet of Things
February 11, 2019| Blog| Viewpoint
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts
Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|
Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|